 Home > Active Ingredient News > Endocrine System > Diabetologia: The likelihood of progression score identifies substations of pre-symptomatic type 1 diabetes in childhood public health screening

Diabetologia: The likelihood of progression score identifies substations of pre-symptomatic type 1 diabetes in childhood public health screening

 Last Update: 2022-09-07
 Source: Internet
 Author: User

Tags

health notes

high color red

elements group similar number

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Background: In patients with advanced (stage 2) symptoms of pre-type 1 diabetes, immunotherapy can delay the onset

As demonstrated by the Fr1da Institute, islet autoantibody screening based on the pediatric population is possible

Objective: The aim of this study was to develop a strategy to identify children with advanced symptoms of pre-type 1 diabetes from the general population and therefore potentially benefit

Methods: We tested children aged 1.

Results: Among the 447 children with multiple islet autoantibodies, 364 children were staged (81.

Figure 1 Progression

Figure 2 A multivariate analysis

Figure 3 Children with type 1 diabetes progress to type 1 diabetes mellitus, stratified based on the likelihood of progression score, to type 3 diabetes

Figure 4 Children with type 2 or type 1 diabetes progress to type 3 and type 1 diabetes, stratified by likelihood of progression

Conclusion: Public health screening of islet autoantibodies found that 0.

Original source: Weiss A, Zapardiel-Gonzalo J, Voss F, et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Empagliflozin

CAS No.: 864070-44-0

Pharmacy Grade

$1134/KG FOB

Yohimbine hydrochloride 98% White crystalline powder

CAS No.: 65-19-0

Pharmacy Grade

$600-620/KG EXW

High Quality Semaglutide 99% powder 910463-68-2-Shaanxi Dideu Medichem Co.Ltd

CAS No.: 910463-68-2

Chemical Grade

$1/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.